Other noncurrent assets Derivative Asset, Noncurrent Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Adjustments to Reconcile Net Income to Cash Flows from Operating Activities: Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Work in process Inventory, Work in Process, Gross Expenditures for long-lived assets Segment, Expenditure, Addition to Long-Lived Assets Unrealized gross losses Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Loss, before Tax Stock repurchase program, remaining authorized amount Share Repurchase Program, Remaining Authorized, Amount Cover [Abstract] Cover [Abstract] Neuroscience Neuroscience [Member] Revenue to unaffiliated customers, Neuroscience Net decrease in cash and cash equivalents Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Other current liabilities Other Liabilities, Current Effect from hedged fixed-rate debt Change in Unrealized Gain (Loss) on Hedged Item in Fair Value Hedge Trading Symbol Trading Symbol Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Fair Value Hedging Fair Value Hedging [Member] 5.1% Notes Due 2035 5.1% Notes Due 2035 [Member] 5.1% Notes Due 2035 All Trading Arrangements All Trading Arrangements [Member] Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Amortization of retirement benefit items Accumulated Defined Benefit Plans Adjustment Including Portion Attributable to Noncontrolling Interest [Member] Non-NEOs Non-NEOs [Member] Revenue, information used to determine revenue recognized, change in accounting estimate, percent (less than) Revenue, Information Used To Determine Revenue Recognized, Change In Accounting Estimate, Percent Revenue, Information Used To Determine Revenue Recognized, Change In Accounting Estimate, Percent Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Accounts receivable, allowances Accounts Receivable, Allowance for Credit Loss, Current Common Stock (no par value) Common Class A [Member] Equity method investments Equity Method Investments Pay vs Performance Disclosure [Line Items] Additional Segment Information Segment Reporting Information, Additional Information [Abstract] Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Net investment gains (losses) on equity securities Net investment (gains) losses on equity securities (Note 6) Equity Securities, FV-NI, Gain (Loss) Cash flow hedges: Cash Flow Hedge [Abstract] Cash Flow Hedge [Abstract] Basis of Presentation and Implementation of New Financial Accounting Standards Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Marketable equity securities Marketable Securities [Member] Marketable Securities [Member] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Hedging Relationship [Domain] Hedging Relationship [Domain] Financial Instruments Fair Value Disclosures [Text Block] Award Timing Disclosures [Line Items] Net Investment Hedges Net Investment Hedging [Member] Other changes in operating assets and liabilities, net of acquisitions and divestitures Increase (Decrease) in Other Operating Assets and Liabilities, Net Other Performance Measure, Amount Other Performance Measure, Amount Portion at Fair Value Measurement Portion at Fair Value Measurement [Member] Other receivables Other Receivables, Net, Current Cash Flow Hedging Cash Flow Hedging [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] U.S. UNITED STATES Service cost Defined Benefit Plan, Service Cost Other noncurrent assets Other Assets, Noncurrent Entity Tax Identification Number Entity Tax Identification Number Purchase of treasury shares (in shares) Treasury Stock, Shares, Acquired Retirement Plan Type [Axis] Retirement Plan Type [Axis] Net Cash Provided by Operating Activities Net Cash Provided by (Used in) Operating Activities Cash Flows from Operating Activities Net Cash Provided by (Used in) Operating Activities [Abstract] Common Stock in Treasury Treasury Stock, Common [Member] Schedule of Derivative Instruments Schedule of Derivative Instruments [Table Text Block] Short-term income taxes payable Taxes Payable, Current Schedule of Accumulated Other Comprehensive Income (Loss) Schedule of Accumulated Other Comprehensive Income (Loss) [Table Text Block] Buy USD Sell Euro Buy USD Sell Euro [Member] Buy USD Sell Euro [Member] Other Stockholders' Equity, Other Damages awarded, value Loss Contingency, Damages Awarded, Value Prepaid expenses Prepaid Expense, Current Equity Components [Axis] Equity Components [Axis] Other current assets Other Assets, Current Award Timing Method Award Timing Method [Text Block] Net periodic cost Defined Benefit Plan, Net Periodic Benefit Cost (Credit) Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Total Debt Securities, Available-for-Sale Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Derivative asset, notional amount Derivative Asset, Notional Amount Insider Trading Policies and Procedures [Line Items] Adjustment to Compensation, Amount Adjustment to Compensation Amount Additional paid-in capital Additional Paid in Capital, Common Stock Compensation Amount Outstanding Recovery Compensation Amount Unfunded commitments to invest in venture capital funds, anticipated payment period Fair Value, Investments, Entities That Calculate Net Asset Value Per Share, Unfunded Commitments, Payment Period Fair Value, Investments, Entities That Calculate Net Asset Value Per Share, Unfunded Commitments, Payment Period Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Entity Small Business Entity Small Business Company Selected Measure Amount Company Selected Measure Amount Geographical [Axis] Geographical [Axis] Tabular List, Table Tabular List [Table Text Block] Significant Unobservable Inputs (Level 3) Fair Value, Inputs, Level 3 [Member] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Issuance of stock under employee stock plans, net (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Long-term income taxes payable Accrued Income Taxes, Noncurrent Trulicity Trulicity [Member] Trulicity [Member] Fair value of securities in an unrealized loss position Debt Securities, Available-for-Sale, Unrealized Loss Position Equity securities Equity Securities, FV-NI, Current 4.9% Notes Due 2032 4.9% Notes Due 2032 [Member] 4.9% Notes Due 2032 Current Assets Assets, Current [Abstract] Goodwill Goodwill Potential achievements Collaborative Arrangement, Rights and Obligations, Rights (Obligations) Terms or rights and obligations under collaborative arrangements. Ebglyss Ebglyss [Member] Ebglyss Investments in Equity and Debt Securities Fair Value of Financial Instruments, Policy [Policy Text Block] Stock repurchase program, authorized amount Share Repurchase Program, Authorized, Amount Inventories Inventory Disclosure [Text Block] 5.6% Notes Due 2065 5.6% Notes Due 2065 [Member] 5.6% Notes Due 2065 Beginning balance (in shares) Ending balance (in shares) Treasury Stock, Common, Shares Effect from interest rate contracts Change in Unrealized Gain (Loss) on Fair Value Hedging Instruments Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Product and Service [Domain] Product and Service [Domain] Employee Stock Option Share-Based Payment Arrangement, Option [Member] Schedule of Effective Portion of Risk-Management Instruments that was Recognized in Other Comprehensive Income (Loss), Net Investment Hedges Schedule of Net Investment Hedges in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Chugai Chugai [Member] Chugai Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Less: Less Significant Expenses [Abstract] Less Significant Expenses Other financing activities, net Proceeds from (Payments for) Other Financing Activities Comprehensive income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Defined Benefit Pension Plans Pension Plan [Member] Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration] Derivative Liability, Current, Statement of Financial Position [Extensible Enumeration] Security Exchange Name Security Exchange Name Schedule of the Contractual Maturities of Our Investments in Debt Securities Measured at Fair Value Investments Classified by Contractual Maturity Date [Table Text Block] Award Type Award Type [Axis] Corporate debt securities Corporate Debt Securities [Member] Reclassification out of Accumulated Other Comprehensive Income Reclassification out of Accumulated Other Comprehensive Income [Member] Total (approximates replacement cost) Inventory, Gross Other, net of tax Accumulated Gain (Loss), Net, Cash Flow Hedge And Foreign Currency Adjustment, Including Portion Attributable To Noncontrolling Interest [Member] Accumulated Gain (Loss), Net, Cash Flow Hedge And Foreign Currency Adjustment, Including Portion Attributable To Noncontrolling Interest Property and equipment, net of accumulated depreciation of $12,146.9 (2025) and $11,789.0 (2024) Property, Plant and Equipment, Net Number of patents Loss Contingency, Number Of Patents Loss Contingency, Number Of Patents Noncontrolling interests Equity, Attributable to Noncontrolling Interest Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Schedule of the Fair Value of Available-for-Sale Securities in an Unrealized Gain or Loss Position Unrealized Gain (Loss) on Investments [Table Text Block] Expiration Date Trading Arrangement Expiration Date Cash Flows from Investing Activities Net Cash Provided by (Used in) Investing Activities [Abstract] Reclassification out of Accumulated Other Comprehensive Income [Table] Reclassification out of Accumulated Other Comprehensive Income [Table] Total Shareholder Return Amount Total Shareholder Return Amount Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Issued More Than 10 Years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 10 Entity [Domain] Entity [Domain] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Asset impairment, restructuring, and other special charges Restructuring Costs and Asset Impairment Charges Taltz Taltz [Member] Taltz [Member] Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Early-stage Early-Stage [Member] Early-Stage Property and equipment, accumulated depreciation Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Effective portion of risk-management instruments that was recognized in other comprehensive income (loss) Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), before Reclassification and Tax Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Europe Europe [Member] Verzenio Verzenio [Member] Verzenio [Member] Diluted (in shares) Weighted Average Number of Shares Outstanding, Diluted Derivative liability, notional amount Derivative Liability, Notional Amount MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Total Eli Lilly and Company shareholders' equity Beginning balance Ending balance Equity, Attributable to Parent Collaborations and Other Arrangements Collaborative Arrangement Disclosure [Text Block] Less Than 1 Year Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, Year One Recognized actuarial gain (loss) Defined Benefit Plan, Amortization of Gain (Loss) Litigation Case [Axis] Litigation Case [Axis] Interest expense Interest expense Interest Expense, Nonoperating Hedging Designation [Domain] Hedging Designation [Domain] Other receivables Derivative Asset, Current Effective portion of losses on interest rate contracts reclassified from accumulated other comprehensive loss Other Comprehensive Income (Loss), Cash Flow Hedge, Gain (Loss), Reclassification, before Tax Employee Benefit Trust Trust for Benefit of Employees [Member] Marketing, selling, and administrative Selling, General and Administrative Expense Proceeds from sales of and distributions from noncurrent investments Proceeds from Sale and Maturity of Other Investments Short-term borrowings and current maturities of long-term debt Debt, Current Other comprehensive income, net of tax (Note 10) Other comprehensive income, net of tax Net other comprehensive income (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent Accounts receivable, net of allowances of $15.5 (2025) and $14.9 (2024) Accounts Receivable, after Allowance for Credit Loss, Current Net product revenue Product [Member] Long-term debt Long-term debt, including current portion Long-Term Debt Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Document Fiscal Period Focus Document Fiscal Period Focus Employee Litigation, July 2019 Ruling Employee Litigation, July 2019 Ruling [Member] Employee Litigation, July 2019 Ruling All Executive Categories All Executive Categories [Member] Sales returns, rebates, and discounts Sales Returns and Allowances [Member] Net Unrealized Gains (Losses) on Available-For-Sale Securities AOCI, Accumulated Gain (Loss), Debt Securities, Available-for-Sale, Parent [Member] Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Assets Assets [Abstract] Retirement Plan Type [Domain] Retirement Plan Type [Domain] Other oncology Other Oncology [Member] Other Oncology [Member] Document Type Document Type Employee Litigation, July 2018 Ruling Employee Litigation, July 2018 Ruling [Member] Employee Litigation, July 2018 Ruling Derivative Contract [Domain] Derivative Contract [Domain] Commercial Paper Commercial Paper [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] Schedule of Segment Reporting Information, by Segment Schedule of Segment Reporting Information, by Segment [Table Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Purchases of in-process research and development Payments to Acquire in Process Research and Development Cash and cash equivalents at January 1 Cash and Cash Equivalents at March 31 Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations Hedged Fixed Rate Debt Hedged Fixed Rate Debt [Member] Hedged Fixed-Rate Debt [Member] Schedule of Defined Benefit Plans Disclosures [Table] Defined Benefit Plan [Table] Late-stage Late-Stage [Member] Late-Stage Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] Outside U.S. Non-US [Member] Accounts payable Accounts Payable, Current Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Contingencies Commitments and Contingencies, Policy [Policy Text Block] Variable rate Long-Term Debt, Percentage Bearing Variable Interest, Percentage Rate Acquisitions Business Combination Disclosure [Text Block] Current Fiscal Year End Date Current Fiscal Year End Date Short-term investments (Note 6) Short-Term Investments PEO Name PEO Name Fair value hedges: Fair Value Hedge [Abstract] Fair Value Hedge [Abstract] Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Actuarial losses, net Accumulated Defined Benefit Plans Adjustment, Net Gain (Loss) Including Portion Attributable to Noncontrolling Interest [Member] Income before income taxes Total before tax Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount All Award Types Award Type [Domain] Name Outstanding Recovery, Individual Name Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Increase to last-in, first-out (LIFO) cost Inventory, LIFO Reserve Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] Accrued retirement benefits (Note 8) Liability, Defined Benefit Plan, Noncurrent Deferred tax assets Deferred Income Tax Assets, Net Non-PEO NEO Non-PEO NEO [Member] Other comprehensive income (loss) before reclassifications OCI, before Reclassifications, Net of Tax, Attributable to Parent Additional Paid-in Capital Additional Paid-in Capital [Member] Hedging Relationship [Axis] Hedging Relationship [Axis] Award Timing Predetermined Award Timing Predetermined [Flag] Unfavorable Regulatory Action Unfavorable Regulatory Action [Member] Retirement Benefits Retirement Benefits [Text Block] Brazil BRAZIL Swap Swiss Francs to U.S. Dollars Swap Swiss Francs To U.S. Dollars [Member] Swap Swiss Francs To U.S. Dollars [Member] Implementation of New Financial Accounting Standards New Accounting Pronouncements, Policy [Policy Text Block] Amortization of prior service cost Defined Benefit Plan, Amortization of Prior Service Cost (Credit) Diluted (in dollars per share) Earnings Per Share, Diluted Class of Stock [Axis] Class of Stock [Axis] Name Measure Name Entity Interactive Data Current Entity Interactive Data Current Prior service costs (benefits), net Accumulated Defined Benefit Plans Adjustment, Net Prior Service Including Portion Attributable to Noncontrolling Interest [Member] Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] 7 1/8% Notes due 2025 7 1/8% Notes Due June 1, 2025 [Member] 7 1/8% Notes Due June 1, 2025 [Member] Retirement Benefits [Abstract] Retirement Benefits [Abstract] Asset impairment, restructuring, and other special charges Restructuring, Settlement and Impairment Provisions Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] China CHINA 0.500% Notes due 2033 .500% Notes Due 2033 [Member] .500% Notes Due 2033 [Member] Asset-backed securities Asset-Backed Securities [Member] Stock-based compensation expense Share-Based Payment Arrangement, Noncash Expense Net income (loss) Total reclassifications, net of tax Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Retirement Benefit Plans Accumulated Defined Benefit Plans Adjustment Attributable to Parent [Member] Income taxes (Note 7) Tax benefit Income taxes Income Tax Expense (Benefit) Costs, expenses, and other Cost Of Sales, Operating Expenses, And Other-net Cost Of Sales, Operating Expenses, And Other-net Interest cost Defined Benefit Plan, Interest Cost Nonoperating Income (Expense) [Abstract] Nonoperating Income (Expense) [Abstract] Stated interest rate Debt Instrument, Interest Rate, Stated Percentage Short-term investments Debt Securities, Available-for-Sale, Current Immunology Immunology [Member] Immunology [Member] Zepbound Zepbound [Member] Zepbound Sell Chinese Yuan Sell Chinese Yuan [Member] Sell Chinese Yuan Other–net, (income) expense (Note 11) Other–net, (income) expense Nonoperating Income (Expense) Reclassification out of Accumulated Other Comprehensive Income [Domain] Reclassification out of Accumulated Other Comprehensive Income [Domain] Statement of Comprehensive Income [Abstract] Statement of Comprehensive Income [Abstract] Effective income tax rates, percentage Effective Income Tax Rate Reconciliation, Percent Net Cash Used for Investing Activities Net Cash Provided by (Used in) Investing Activities AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward] Research and development Research and Development Expense (Excluding Acquired in Process Cost) Number of reportable segments Number of Reportable Segments Total liabilities and equity Liabilities and Equity Other operating activities, net Other Operating Activities, Cash Flow Statement Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] All Adjustments to Compensation All Adjustments to Compensation [Member] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Employee compensation Employee-related Liabilities, Current Short-Term Debt, Type [Domain] Short-Term Debt, Type [Domain] Hedging Designation [Axis] Hedging Designation [Axis] Other current liabilities Derivative Liability, Current Schedule of Other–Net, (Income) Expense Schedule of Other Nonoperating Income (Expense) [Table Text Block] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Table] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Accumulated Other Comprehensive Income (Loss) [Line Items] Other cardiometabolic health Other Cardiometabolic Health [Member] Other Cardiometabolic Health Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Interest income Interest income Investment Income, Interest Legal Entity [Axis] Legal Entity [Axis] Dividends paid Payments of Dividends Underlying Security Market Price Change Underlying Security Market Price Change, Percent Expected return on plan assets Defined Benefit Plan, Expected Return (Loss) on Plan Assets Individual: Individual [Axis] Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Net Unrealized Gains (Losses) on Cash Flow Hedges Accumulated Gain (Loss), Net, Cash Flow Hedge, Parent [Member] Inventories (Note 5) Inventories Inventory, Net U.S. government and agency securities US Government Agencies Debt Securities [Member] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Product and Service [Axis] Product and Service [Axis] Entity Address, State or Province Entity Address, State or Province Statement [Line Items] Statement [Line Items] Retirement benefit plans Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component Other Other Product, Total [Member] Other Product, Total [Member] Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Defined Benefit Plan Disclosure [Line Items] Defined Benefit Plan Disclosure [Line Items] Cost Portion at Other than Fair Value Measurement [Member] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Financial Instruments [Domain] Financial Instruments [Domain] Liabilities and Equity Liabilities and Equity [Abstract] Offsetting Assets [Line Items] Offsetting Assets [Line Items] Schedule of Net Pension and Retiree Health (Benefit) Cost Schedule of Net Benefit Costs [Table Text Block] Derivatives Derivatives, Policy [Policy Text Block] Reportable Segment Reportable Segment [Member] Reportable Segment Restatement Determination Date Restatement Determination Date Estimate of Fair Value Measurement Estimate of Fair Value Measurement [Member] Noncurrent investments Debt Securities, Available-for-Sale, Noncurrent Adoption Date Trading Arrangement Adoption Date Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Interest Rate Contracts Interest Rate Contract [Member] 6-10 Years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year 5 Through 10 Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Segments [Axis] Segments [Axis] Short-Term Debt, Type [Axis] Short-Term Debt, Type [Axis] 2.125% Notes due 2030 2.125% Notes Due June 3, 2030 [Member] 2.125% Notes Due June 3, 2030 [Member] Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Milestone Payments, Sales-based Milestone Payments, Sales-based [Member] Milestone Payments, Sales-based [Member] Schedule of Fair Value Information, Liabilities Fair Value, Liabilities Measured on Recurring Basis [Table Text Block] Equity method investments Payments to Acquire Equity Method Investments Derivative Instrument [Axis] Derivative Instrument [Axis] Exercise Price Award Exercise Price Dividends payable Dividends Payable, Current Ilya Yuffa [Member] Ilya Yuffa Arrangement Duration Trading Arrangement Duration Schedule of Effective Portion of Risk-Management Instruments that was Recognized in Other Comprehensive Income (Loss), Cash Flow Hedges Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss) [Table Text Block] Issuance of stock under employee stock plans, net Stock Issued During Period, Value, Employee Stock Purchase Plan Costs, expenses, and other: Costs and Expenses [Abstract] One Time Payment One Time Payment [Member] One Time Payment Net investment (gains) losses Gain (Loss) on Investments Investments (Note 6) Noncurrent investments Long-Term Investments Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Segments [Domain] Segments [Domain] Other securities Other Debt Obligations [Member] Benefit (expense) for income taxes allocated to other comprehensive income (loss) Other Comprehensive Income (Loss), Tax Financial Information Regularly Reviewed by the CODM Segment Reporting Information, Profit (Loss) [Abstract] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] All Individuals All Individuals [Member] PEO PEO [Member] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Name Trading Arrangement, Individual Name Other–net, (income) expense Other (income) expense Other Nonoperating Income (Expense) Retiree Health Benefit Plans Other Postretirement Benefits Plan [Member] Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Other intangibles, net Intangible Assets, Net (Excluding Goodwill) Effective portion of risk-management instruments that was recognized in other comprehensive income (loss) Other Comprehensive Income (Loss), Net Investment Hedge, Gain (Loss), before Reclassification and Tax Proceeds from sales of available-for-sale investments Proceeds From Sale Of Equity And Available For Sale Securities Proceeds From Sale Of Equity And Available For Sale Securities Unrealized gross gains Debt Securities, Available-for-Sale, Accumulated Gross Unrealized Gain, before Tax 4.550% Notes Due 2028 4.550% Notes Due 2028 [Member] 4.550% Notes Due 2028 Earnings (loss) in equity method investments Income (Loss) from Equity Method Investments Cost of common stock in treasury Treasury Stock, Common, Value Business Combination, Asset Acquisition, and Joint Venture Formation [Abstract] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Total noncurrent liabilities Liabilities, Noncurrent Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount Net losses on foreign currency exchange contracts not designated as hedging instruments Gain (Loss) on Foreign Currency Derivative Instruments Not Designated as Hedging Instruments Local Phone Number Local Phone Number Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] Average remaining maturity of foreign currency derivatives Average Remaining Maturity of Foreign Currency Derivatives Change in Accounting Estimate by Type [Axis] Change in Accounting Estimate by Type [Axis] Maximum remaining maturity of foreign currency derivatives Maximum Remaining Maturity of Foreign Currency Derivatives Noncurrent Liabilities Liabilities, Noncurrent [Abstract] PEO Total Compensation Amount PEO Total Compensation Amount Contingencies Commitments and Contingencies Disclosure [Text Block] Common Stock Common Stock [Member] Measure: Measure [Axis] Stock-based compensation Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Accounts receivable derecognized Transfer of Financial Assets Accounted for as Sales, Amount Derecognized Unfunded commitments to invest in venture capital funds Fair Value, Investments, Entities that Calculate Net Asset Value Per Share, Unfunded Commitments Entity Emerging Growth Company Entity Emerging Growth Company 1.700% Notes due 2049 1.700% Notes Due 2049 [Member] 1.700% Notes due 2049 [Member] Segment Reporting [Abstract] Segment Reporting [Abstract] Entity Central Index Key Entity Central Index Key Other segment items Segment Reporting, Other Segment Item, Amount 4.750% Notes Due 2030 4.750% Notes Due 2030 [Member] 4.750% Notes Due 2030 Schedule of Components of Inventories Schedule of Inventory, Current [Table Text Block] Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Foreign Currency Translation Gains (Losses) Accumulated Foreign Currency Adjustment Attributable to Parent [Member] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Change in Accounting Estimate [Line Items] Change in Accounting Estimate [Line Items] Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] Equity Component [Domain] Equity Component [Domain] Financial Instrument [Axis] Financial Instrument [Axis] Segment Information Segment Reporting Disclosure [Text Block] Other immunology Other Immunology [Member] Other Immunology [Member] Japan JAPAN Schedule of Effects of Risk-Management Instruments Were Recognized in Other–Net, (Income) Expense Schedule of Derivatives Instruments Statements of Financial Performance and Financial Position, Location [Table Text Block] Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Entity Shell Company Entity Shell Company Measurement Basis [Axis] Measurement Basis [Axis] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Schedule of Change in Accounting Estimate [Table] Change in Accounting Estimate [Table] 1.625% Notes due 2043 1.625% Notes Due 2043 [Member] 1.625% Notes Due 2043 Title Trading Arrangement, Individual Title 5.5% Notes Due 2055 5.5% Notes Due 2055 [Member] 5.5% Notes Due 2055 Statement [Table] Statement [Table] City Area Code City Area Code Current Liabilities Liabilities, Current [Abstract] Other noncurrent liabilities Business Combination, Contingent Consideration, Liability Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Quoted Prices in Active Markets for Identical Assets (Level 1) Fair Value, Inputs, Level 1 [Member] Total current assets Assets, Current Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Senior Notes Senior Notes [Member] Purchases of common stock Payments for Repurchase of Common Stock Foreign Currency Denominated Debt Foreign Currency Denominated Debt [Member] Foreign Currency Denominated Debt [Member] Rest of world Rest Of World [Member] Rest Of World Document Information [Line Items] Document Information [Line Items] Long-term debt Long-Term Debt, Excluding Current Maturities Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Accumulated Other Comprehensive Income (Loss) [Table] Accumulated Other Comprehensive Income (Loss) [Table] Equity investments without readily determinable fair values Equity Securities without Readily Determinable Fair Value, Amount Change in Accounting Estimate, Type [Domain] Change in Accounting Estimate, Type [Domain] Income Taxes Income Tax Disclosure [Text Block] 0.625% Notes due 2031 .625% Notes Due 2031 [Member] .625% Notes due 2031 [Member] Earnings per share: Earnings Per Share [Abstract] Emgality Patent Litigation Emgality Patent Litigation [Member] Emgality Patent Litigation [Member] Equity [Abstract] Equity [Abstract] Retained earnings Retained Earnings (Accumulated Deficit) Schedule of Reclassifications Out of Accumulated Other Comprehensive Loss Reclassification out of Accumulated Other Comprehensive Income [Table Text Block] Class of Stock [Domain] Class of Stock [Domain] Retirement of treasury shares (in shares) Treasury Stock, Shares, Retired Sell Euro Sell Euro [Member] Sell Euro [Member] 1.125% Notes due 2051 1.125% Notes Due 2051 [Member] 1.125% Notes Due 2051 1.625% Notes due 2026 1.625% Notes Due June 2, 2026 [Member] 1.625% Notes Due June 2, 2026 [Member] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Equity Awards Adjustments Equity Awards Adjustments [Member] Net change in short-term borrowings Proceeds from (Repayments of) Short-Term Debt Net Cash Provided by (Used for) Financing Activities Net Cash Provided by (Used in) Financing Activities Orforglipron Orforglipron [Member] Orforglipron Underlying Securities Award Underlying Securities Amount Amendment Flag Amendment Flag Loss Contingency Nature [Axis] Loss Contingency Nature [Axis] Short-term commercial paper borrowings Commercial Paper Carrying Amount Reported Value Measurement [Member] Entity Registrant Name Entity Registrant Name Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Depreciation and amortization Depreciation, Depletion and Amortization Reclassification out of Accumulated Other Comprehensive Income [Axis] Reclassification out of Accumulated Other Comprehensive Income [Axis] Fair Value as of Grant Date Award Grant Date Fair Value Other–Net, (Income) Expense Other Income and Other Expense Disclosure [Text Block] Significant Other Observable Inputs (Level 2) Fair Value, Inputs, Level 2 [Member] Fair Value Hierarchy and NAV [Domain] Fair Value Hierarchy and NAV [Domain] Offsetting Assets [Table] Offsetting Assets [Table] Eli Lilly and Company Shareholders' Equity Equity, Including Portion Attributable to Noncontrolling Interest [Abstract] Geographical [Domain] Geographical [Domain] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Debt instrument, face amount Debt Instrument, Face Amount Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Other noncurrent liabilities Derivative Liability, Noncurrent Entity Address, Postal Zip Code Entity Address, Postal Zip Code Collaborative Arrangements and Non-collaborative Arrangements [Axis] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Forward-starting interest rate swaps Interest Rate Swap [Member] Restatement Determination Date: Restatement Determination Date [Axis] Collaborative Arrangements and Non-collaborative Arrangement Transactions [Domain] Collaborative Arrangement and Arrangement Other than Collaborative [Domain] Title of 12(b) Security Title of 12(b) Security Common stock Common Stock, Value, Issued Number of sites jointly and severally liable for cleanup (fewer than) Loss Contingency, Number Of Sites Jointly And Severally Liable For Cleanup Loss Contingency, Number Of Sites Jointly And Severally Liable For Cleanup Oncology Oncology [Member] Revenue to unaffiliated customers, Oncology Cash and cash equivalents (Note 6) Cash and Cash Equivalents, at Carrying Value Milestone Payments, Development and Regulatory Milestone Payments, Development and Regulatory [Member] Milestone Payments, Development and Regulatory [Member] Other investing activities, net Payments for (Proceeds from) Other Investing Activities Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Raw materials and supplies Inventory, Raw Materials, Gross Cash Flows from Financing Activities Net Cash Provided by (Used in) Financing Activities [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] 6.77% Notes due 2036 6.77% Notes Due January 1, 2036 [Member] 6.77% Notes Due January 1, 2036 [Member] Sales rebates and discounts Sales Rebates And Discounts Sales Rebates And Discounts Finished products Inventory, Finished Goods, Gross Fair Value Measurement [Domain] Fair Value Measurement [Domain] Basic (in dollars per share) Earnings Per Share, Basic Buy USD Sell GBP Buy USD Sell GBP [Member] Buy USD Sell GBP Purchases of property and equipment Payments to Acquire Other Property, Plant, and Equipment Total Derivative Instruments, Gain (Loss) Recognized Derivative Instruments, Gain (Loss) Recognized Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Foreign currency-denominated notes, designated as hedge Derivatives used in Net Investment Hedge, Net of Tax Acquired in-process research and development (Note 3) Acquired in-process research and development Acquired in-process research and development Research and Development Asset Acquired in Transaction Other than Business Combination or Joint Venture Formation, Writeoff Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Other securities, noncurrent investments Other Equity Securities [Member] Other Equity Securities [Member] Designated as Hedging Instrument Designated as Hedging Instrument [Member] Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Total current liabilities Liabilities, Current Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Shares used in calculation of earnings per share: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Total assets Total assets Assets Schedule of Collaborative Arrangements Collaborative Arrangement and Arrangement Other than Collaborative [Table Text Block] Cost of sales Cost of Goods and Services Sold Schedule of Fair Value Information, Assets Fair Value, Assets Measured on Recurring Basis [Table Text Block] Other noncurrent liabilities Other Liabilities, Noncurrent Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Commitments and Contingencies (Note 9) Commitments and Contingencies Boehringer Ingelheim Boehringer Ingelheim [Member] Boehringer Ingelheim Collaboration and other revenue Collaboration and Other Revenue [Member] Collaboration and Other Revenue [Member] Acquisitions Asset Acquisition [Text Block] Termination Date Trading Arrangement Termination Date Employee benefit trust Common Stock, Shares Held in Employee Trust Mortgage-backed securities Collateralized Mortgage-Backed Securities [Member] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Revenue (Note 2) Revenue Revenues Pre launch inventory capitalized Inventory, Capitalized, Gross Inventory, Capitalized, Gross Not Designated as Hedging Instrument Not Designated as Hedging Instrument [Member] 1.375% Notes due 2061 1.375% Notes Due 2061 [Member] 1.375% Notes Due 2061 Entity Address, City or Town Entity Address, City or Town Proceeds from issuance of long-term debt Proceeds from Issuance of Long-Term Debt 1-5 Years Debt Securities, Available-for-Sale, Fair Value, Maturity, Allocated and Single Maturity Date, after Year One Through Five Debt Instrument [Axis] Debt Instrument [Axis] Net income Net income Net income Net Income (Loss) Attributable to Parent Trading Arrangement: Trading Arrangement [Axis] Schedule of Fair Value, by Balance Sheet Grouping Fair Value, by Balance Sheet Grouping [Table Text Block] Other Comprehensive Income (Loss) Comprehensive Income (Loss) Note [Text Block] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Jardiance Jardiance Jardiance [Member] Jardiance [Member] Loss Contingencies [Table] Loss Contingencies [Table] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Entity File Number Entity File Number Revenue Revenue from Contract with Customer [Text Block] Document Fiscal Year Focus Document Fiscal Year Focus Noncontrolling Interests Noncontrolling Interest [Member] Income Statement [Abstract] Income Statement [Abstract] Entity Address, Address Line One Entity Address, Address Line One Purchase of treasury shares Treasury Stock, Value, Acquired, Cost Method Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Continuing Operations Name Forgone Recovery, Individual Name Document Period End Date Document Period End Date Loss Contingency, Nature [Domain] Loss Contingency, Nature [Domain] Change in deferred income taxes Increase (Decrease) in Deferred Income Taxes Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Roche Roche [Member] Roche [Member] Cross-currency interest rate swaps Cross Currency Interest Rate Contract [Member] Insider Trading Arrangements [Line Items] Inventory Disclosure [Abstract] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Retirement of treasury shares Treasury Stock, Retired, Cost Method, Amount Buy U.S. Dollars Sell Japanese Yen Buy US dollar Sell Japanese Yen [Member] Buy US dollar Sell Japanese Yen [Member] Buy Euros Sell U.S. Dollars Buy Euro Sell Us Dollar [Member] Foreign Currency Forward Commitment to Buy euro Sell US dollar PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Adjustment to Compensation: Adjustment to Compensation [Axis] Foreign Exchange Contract Foreign Exchange Contract [Member] Transition Report Document Transition Report Quarterly Report Document Quarterly Report Swap U.S. Dollars to Euro Swap U.S. Dollars To Euro [Member] Swap U.S. Dollars To Euro [Member] Purchases of noncurrent investments Payments to Acquire Other Investments Litigation Case Type [Domain] Litigation Case [Domain] Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Accumulated other comprehensive loss (Note 10) Accumulated Other Comprehensive Income (Loss), Net of Tax Entity Current Reporting Status Entity Current Reporting Status Retained Earnings Retained Earnings [Member] Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Basic (in shares) Weighted Average Number of Shares Outstanding, Basic Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Mounjaro Mounjaro [Member] Mounjaro [Member] Document Information [Table] Document Information [Table] Total equity Beginning balance Ending balance Equity, Including Portion Attributable to Noncontrolling Interest Cardiometabolic Health Cardiometabolic Health [Member] Cardiometabolic Health Increase (Decrease) in Shareholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Executive Category: Executive Category [Axis] Name Awards Close in Time to MNPI Disclosures, Individual Name Fair value of securities in an unrealized gain position Debt Securities, Available-For-Sale, Unrealized Gain Position Debt Securities, Available-For-Sale, Unrealized Gain Position Entity Filer Category Entity Filer Category Net amount reclassified from accumulated other comprehensive loss Reclassification from AOCI, Current Period, Net of Tax, Attributable to Parent Loss Contingencies [Line Items] Loss Contingencies [Line Items] Company Selected Measure Name Company Selected Measure Name